United Therapeutics Corporation
NASDAQ:UTHR · NASDAQ Global Select
-$18.01 today
Vol 1.28M · Avg 0.52M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+87.36%
Period High
$596.76
Period Low
$274.70
Latest
$536.59
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Biogen Inc.
NASDAQ:BIIB
$29.03B
Illumina, Inc.
NASDAQ:ILMN
$24.41B
Waters Corporation
NYSE:WAT
$23.24B
West Pharmaceutical Services, Inc.
NYSE:WST
$23.22B
Royalty Pharma plc
NASDAQ:RPRX
$22.69B
Quest Diagnostics Incorporated
NYSE:DGX
$21.48B
Incyte Corporation
NASDAQ:INCY
$19.60B
Zimmer Biomet Holdings, Inc.
NYSE:ZBH
$17.05B
Genmab A/S
NASDAQ:GMAB
$15.56B
Tenet Healthcare Corporation
NYSE:THC
$14.82B
What is the latest UTHR filing?
The latest filing shown is 4 dated Jun 17, 2026.
How many recent filings does UTHR have?
Intrinsic Alpha currently shows 20 recent filings for UTHR.
Explore More
Continue the stock analysis
Jump to another research area for this company.